-
公开(公告)号:US12144825B2
公开(公告)日:2024-11-19
申请号:US16625678
申请日:2018-07-02
Applicant: CELLECTIS
Inventor: David Sourdive , Aymeric Duclert , Mathieu Simon , Philippe Duchateau , Alan Marc Williams , Laurent Poirot
IPC: A61K35/17 , A61K39/00 , C12Q1/6881
Abstract: The present invention provides composition kits and methods for treating cancer in a human by immunotherapy using successive doses of CAR-T cells with no or reduced anamnestic immune reaction in one individual (P).